NVP-BAG956 is an ATP-competitive PI3K inhibitor with IC50s of 34, 56, 112 and 444 nM for PI3Kδ, PI3Kα, PI3Kγ and PI3Kβ, respectively.
性状
Solid
IC50 & Target[1][2]
PI3Kα
56 nM (IC50)
PI3Kβ
446 nM (IC50)
PI3Kδ
35 nM (IC50)
PI3Kγ
117 nM (IC50)
VEGFR1
2.56 μM (IC50)
PDK1
240 nM (IC50)
体外研究(In Vitro)
NVP-BAG956 also inhibits PDK1 with an IC50 of 240/260 nM. NVP-BAG956 also inhibits VEGFR1 with an IC50 of 2.56±0.56 μM. NVP-BAG956 blocks phosphorylation of PKB/Akt in A2058 cells with an IC50 value of 67±25 nM. Inhibition of PKB/Akt phosphorylation correlated with loss of A2058 cell proliferation for NVP-BAG956 (IC50=290±20 nM). In the presence of NVP-BAG956, A2058 cells are only able to exit G2-M and then remain in G1. The p27 expression is clearly induced by NVP-BAG956 in A2058 cells but not in C32 cells.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.